LaMontagne Center for Infectious Disease at UT

Your gift can also support the Richard J. Meyer Endowed Lectureship, bringing cutting‑edge scientific insights to LCID faculty, students, and postdoctoral fellows. Give today: https://www.givecampus.com/s/9jdc55

It’s the final day of ! LCID research is shaping the prevention and treatment of infectious diseases worldwide. Join us and give today. https://www.givecampus.com/s/9jdc55

LCID members bring expertise across 30+ infectious diseases, studying viral and bacterial mutations, antibiotic resistance, biotechnology, biofilms, nanomedicine, and vaccines. Help advance this vital research today: https://www.givecampus.com/s/9jdc55

UT's 40 Hours for the Forty Acres campaign starts today! The time to give is NOW to support the LaMontagne Center for Infectious Disease and the important work its researchers do! https://www.givecampus.com/s/9jdc55

We are less than a week away from our 40 Hours for the Forty Acres annual fundraising event on April 29-30, 2026. Help us change the world by supporting our infectious disease research!

The Davies Lab has uncovered a surprising new role for microcins. Known for killing competing bacteria, these proteins can also form amyloid fibers that help build biofilms—revealing a dual life as both toxin and structural support. See:

Davies Lab Discovers New Role for Microsins Davies Lab Discovers New Role for Microsins

The Bayer-Santos Lab, along with researchers at the University of São Paulo, have discovered salmonella toxins that could lead to healthier microbiomes and new targetted antibacterial therapies. See:

A Secret Weapon from Salmonella Could Help Us Maintain Healthier Microbiomes The discovery could also lend itself to the development of future antibacterial therapies.

Researchers in the Davies Lab at UT and NIH reveal the first high-res structure of a microcin binding its bacterial receptor—offering more insight in fighting drug-resistant infections.
Learn more:

High-Resolution Structure Reveals How Microcins Target Bacteria High-Resolution Structure Reveals How Microcins Target Bacteria

Congratulations to LCID member Dr. Jason McLellan on receiving a 2025 MacArthur Fellowship for his groundbreaking work in structural biology and infectious disease interventions!

Virus Slayer Awarded ‘Genius Grant’ by MacArthur Foundation The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

LCID member Dr. Bryan Davies and his lab have found a new method to help antibodies kill bacteria. Their paper in the journal PNAS describes how: https://lcid.utexas.edu/news/research/re-engineered-antibodies-kill-bacteria-directly

SAVE THE DATE: Dr. Vincent Young, MD, PhD, to present the 2025 Richard Meyer Lecture on Nov. 11.

Vincent Young at the 2025 Richard J. Meyer Lecture Dr. Vincent Young, professor at the University of Michigan Medical School will present the 2025 Richard J. Meyer Lecture.